VLTO

Veralto Corporation

$83.48

-1.16%
May 28, 2026
Bobby Quantitative Model
Veralto Corporation is a diversified industrial firm operating in the Pollution & Treatment Controls industry, organized into two core segments: Water Quality, which provides analytics and treatment solutions, and Product Quality & Innovation, which offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. The company is a significant player in essential industrial niches, leveraging its spin-off from Danaher to establish itself as a pure-play entity focused on mission-critical quality and safety applications. The current investor narrative centers on its performance as a newly independent public company, with attention on its ability to deliver consistent organic growth and margin expansion amidst a challenging macroeconomic environment, as evidenced by recent quarterly results and analyst rating actions.

People also watch

Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corporation

ZWS

Analysis
Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc.

ATMU

Analysis
Caterpillar Inc.

Caterpillar Inc.

CAT

Analysis
GE Aerospace

GE Aerospace

GE

Analysis
RTX

RTX

RTX

Analysis

VLTO 12-Month Price Forecast

Historical Price
Current Price $83.48
Average Target $83.48
High Target $96.002
Low Target $70.958

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Veralto Corporation's 12-month outlook, with a consensus price target around $108.52 and implied upside of +30.0% versus the current price.

Average Target

$108.52

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$67 - $109

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Analyst coverage is limited, with only 5 analysts providing estimates, indicating this is a relatively new or niche coverage name following its 2023 spin-off. The consensus leans neutral, with recent institutional ratings from firms like RBC Capital and Citigroup maintaining 'Sector Perform' and 'Neutral' stances, respectively, though a notable downgrade from Jefferies from 'Buy' to 'Hold' in December 2025 signals growing caution. The average revenue estimate for the coming period is $6.63 billion, with a tight range between $6.53B and $6.73B, and an average EPS estimate of $5.36, ranging from $5.26 to $5.47. The narrow target range for estimates suggests analysts have relatively high conviction in the company's near-term financial trajectory, but the limited number of covering analysts and lack of explicit price targets in the data imply higher uncertainty and potential for volatility due to less efficient price discovery typical of newer spin-offs.

Drowning in data?

Find the real signal!

Bulls vs Bears: VLTO Investment Factors

The bull case for Veralto rests on its high-quality financials: exceptional cash flow, strong margins, and a defensive, recurring revenue model that justify a premium valuation. The bear case, however, is currently more compelling, driven by the stark disconnect between its premium valuation multiples and its anemic low-single-digit revenue growth, exacerbated by severe technical deterioration and negative market sentiment. The single most important tension in the investment debate is whether the company's superior profitability and cash generation can eventually outweigh and justify its current growth challenges, or if the market will continue to re-rate the stock lower until growth accelerates or valuation becomes deeply compelling.

Bullish

  • Strong Profitability & Cash Flow: Veralto generates robust free cash flow of $1.014 billion TTM and maintains high margins, with a gross margin of 59.9% and an operating margin of 23.2%. This cash generation supports a healthy balance sheet (D/E of 0.86) and funds shareholder returns, including a dividend.
  • Attractive Forward Valuation Discount: The stock trades at a forward P/E of 18.7x, a significant discount to its trailing P/E of 26.4x, implying the market expects earnings growth. This forward multiple is more reasonable for an industrial company with its margin profile.
  • High-Quality, Recurring Revenue Base: Approximately 61% of revenue ($1.702B of $2.8B total) comes from recurring contracts, providing predictable cash flow and resilience. This model is typical of its Danaher heritage and supports stable earnings.
  • Mission-Critical, Defensive End Markets: Operations in water quality and product quality for CPG/pharma are essential services, offering some insulation from economic cycles. The company's low beta of 0.927 confirms its lower volatility relative to the market.

Bearish

  • Persistent Weak Growth Trajectory: Revenue growth is anemic, with Q4 2025 YoY growth of just 3.8%. This low-single-digit trend, coupled with a 1-year stock price decline of -14%, signals a lack of growth catalysts and investor disinterest.
  • Premium Valuation vs. Sluggish Growth: Despite modest growth, valuation multiples remain elevated (P/S of 4.5x, EV/EBITDA of 18.9x) compared to typical industrials. The PEG ratio of 2.1 indicates the stock is expensive relative to its growth rate.
  • Severe Technical & Relative Underperformance: The stock is in a pronounced downtrend, underperforming the SPY by over 41% in the past year. Trading near its 52-week low of $84.45, it shows no signs of momentum reversal, with a high short ratio of 2.68 indicating strong bearish sentiment.
  • Limited Analyst Conviction & Coverage: Only 5 analysts cover the stock, and recent actions include a downgrade from Jefferies (Buy to Hold). The neutral consensus ('Sector Perform') and lack of explicit price targets suggest limited conviction in a near-term rebound.

VLTO Technical Analysis

The stock is in a pronounced downtrend, with a 1-year price change of -14.04% and a 6-month decline of -12.31%, significantly underperforming the SPY's 27.88% and 13.14% gains over the same periods, respectively. Currently trading at $86.8, the price sits near the bottom of its 52-week range, approximately 21% above the 52-week low of $84.45 and 21% below the 52-week high of $110.11, indicating the stock is in a value-seeking zone but remains under heavy selling pressure. Recent momentum shows continued weakness, with the stock down 2.47% over the past month and 6.75% over the past three months, a divergence from the broader market's positive momentum (SPY up 4.84% and 8.15%), signaling persistent relative weakness and a lack of near-term catalysts for reversal. Key technical support is clearly defined at the 52-week low of $84.45, while resistance lies at the recent failed recovery level near $103 and the 52-week high of $110.11; a breakdown below $84.45 could trigger further selling, while a sustained move above $100 would be necessary to signal a trend reversal. The stock's beta of 0.927 indicates it is slightly less volatile than the market, but its deep underperformance and high short ratio of 2.68 suggest it is facing significant fundamental and sentiment headwinds.

Beta

0.93

0.93x market volatility

Max Drawdown

-23.9%

Largest decline past year

52-Week Range

$80-$110

Price range past year

Annual Return

-17.1%

Cumulative gain past year

PeriodVLTO ReturnS&P 500
1m-2.5%+6.0%
3m-14.3%+10.0%
6m-17.5%+10.4%
1y-17.1%+28.4%
ytd-15.2%+10.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

VLTO Fundamental Analysis

Revenue growth has been modest but positive, with Q4 2025 revenue of $1.396 billion representing a 3.8% year-over-year increase, continuing a trend of low-single-digit growth visible across recent quarters (Q3 2025: $1.404B, Q2 2025: $1.371B). Segment data reveals a revenue mix of $1.702 billion from recurring contracts and $1.098 billion from non-recurring contracts, providing a base of predictable income, though overall growth trajectory remains muted. The company is solidly profitable, with Q4 2025 net income of $254 million and a trailing net margin of 17.1%, supported by a robust gross margin of 59.9%. Profitability metrics have shown stability, with operating margin at 23.2% and EBITDA margin at 23.9% for the latest quarter, indicating effective cost control despite the modest top-line growth. The balance sheet is healthy with a current ratio of 1.67 and a debt-to-equity ratio of 0.86, reflecting a manageable leverage profile. Cash flow generation is strong, with trailing twelve-month free cash flow of $1.014 billion and an ROE of 30.3%, demonstrating the company's ability to convert profits into cash and deliver solid returns on shareholder equity, which supports its dividend and potential for reinvestment.

Quarterly Revenue

$1.4B

2025-12

Revenue YoY Growth

+0.03%

YoY Comparison

Gross Margin

+0.59%

Latest Quarter

Free Cash Flow

$1.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Revenue from Contract with Customer, Measurement, Nonrecurring
Revenue from Contract with Customer, Measurement, Recurring

Open an Account, get $2 TSLA now!

Valuation Analysis: Is VLTO Overvalued?

Given a positive net income of $254 million, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 26.4x and a forward PE of 18.7x based on estimated EPS of $5.36; the significant discount of the forward multiple implies the market expects earnings growth and a normalization from recent depressed levels. Compared to sector averages, the valuation presents a mixed picture: the trailing PE of 26.4x is above typical industrial averages, while the Price-to-Sales ratio of 4.5x and EV/EBITDA of 18.9x are also at premiums, suggesting the market prices Veralto for its high-quality margins and cash flow generation despite its growth challenges. Historically, the current trailing PE of 26.4x is below its own peak levels seen in late 2024 (e.g., 31.2x in Q3 2024) but above the lower end of its historical band, indicating the stock is not at a deep historical discount but has de-rated from prior optimism, possibly reflecting concerns over growth sustainability.

PE

26.4x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 21x~62x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

18.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Veralto's primary financial risk is its valuation premium in the face of sluggish growth. Trading at a P/E of 26.4x (trailing) and a P/S of 4.5x—multiples typically reserved for faster-growing companies—it faces significant compression risk if growth fails to accelerate. While the balance sheet is healthy (D/E 0.86), the company's dependence on maintaining its high 59.9% gross margin and 23.2% operating margin to support earnings is critical; any material cost inflation or pricing pressure could disproportionately impact net income, given the low revenue growth buffer.

Market & Competitive Risks: The stock faces acute market sentiment and valuation risks. It trades at a substantial premium to typical industrial sector averages on most metrics (EV/EBITDA of 18.9x), yet has dramatically underperformed the market (relative strength of -41.9% over 1 year). This creates a 'value trap' perception. Furthermore, as a newly independent spin-off with limited analyst coverage (5 firms), it is vulnerable to sentiment shifts and lacks the dedicated investor base of its former parent, Danaher, increasing its susceptibility to sector rotations out of industrials.

Worst-Case Scenario: The worst-case scenario involves a continuation of the current trend: low-single-digit growth persists, leading to an earnings miss and multiple compression. This could trigger a cascade of analyst downgrades and institutional selling, breaking key technical support at the 52-week low of $84.45. Given the stock's 22.7% maximum drawdown and high short interest, a panic sell-off could drive the price toward the $75-$80 range, representing a downside of 10-15% from the current $86.8. This scenario would validate the bearish view that VLTO's quality attributes are insufficient to command its current valuation without growth.